In 2017, Merck Group invested EUR2.1 billion worldwide in research and development (R&D). The company expects an 8% increase in turnover for the end of 2018, and a 2.8% increase in turnover globally.
Worldwide, 55 million people use on a daily basis the medical drugs in Merck’s portfolio. A total 53,000 employees in 66 countries are engrossed in the manufacturing of the medical drugs in Merck’s portfolio.